Protara Therapeutics Inc. (TARA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.50
0.05 (1.12%)
At close: Jan 28, 2025, 3:59 PM
4.52
0.33%
After-hours Jan 28, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -0.53 | -0.47 | -1.61 | -5.23 | -0.07 | -9.14 | -1.1 | -1.1 | -11.95 | -9.54 | -19.01 | -18.87 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10.81 | n/a | n/a |
PB Ratio | 0.31 | 0.30 | 0.47 | 0.88 | 0.17 | 11.37 | 0.94 | 0.82 | 4.03 | 0.39 | -36.6 | 41.43 |
P/FCF Ratio | -0.57 | -1.14 | -2.16 | -7.21 | -0.07 | -9.96 | -1.47 | -1.31 | -14.38 | -3.17 | -22.4 | -18.12 |
P/OCF Ratio | -0.57 | -1.14 | -2.2 | -7.48 | -0.07 | -10.01 | -1.47 | -1.33 | -14.54 | -3.19 | -22.44 | -18.26 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.39 | n/a | n/a |
Debt / Equity Ratio | 0.08 | 0.06 | 0.04 | 0.01 | n/a | n/a | 0.00 | n/a | n/a | n/a | -1.23 | n/a |
Quick Ratio | 11.17 | 14.81 | 21.38 | 58.13 | 11.96 | 7.55 | 4.71 | 8.42 | 16.12 | 36.19 | 0.55 | 6.40 |
Current Ratio | 11.17 | 15.01 | 21.66 | 58.13 | 11.96 | 7.55 | 4.71 | 8.42 | 16.12 | 36.19 | 0.55 | 6.40 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.03 | n/a | n/a |
Interest Coverage | n/a | -58.98 | -27.34 | -1.01K | n/a | n/a | -117.23 | -148.73 | -144.93 | -8.84 | -8.27 | n/a |
Return on Equity (ROE) | -0.59 | -0.63 | -0.29 | -0.17 | -2.3 | -1.24 | -0.86 | -0.74 | -0.34 | -0.04 | 1.93 | -2.2 |
Return on Assets (ROA) | -0.51 | -0.57 | -0.27 | -0.16 | -2.11 | -1.08 | -0.68 | -0.66 | -0.32 | -0.04 | -1.4 | -1.02 |
Return on Capital (ROIC) | -0.6 | -0.62 | -0.28 | -0.17 | -2.39 | -1.28 | -0.87 | -0.75 | -0.33 | -0.09 | 1.73 | -1.22 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100.00% | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113.36% | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -113.36% | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -257.12% | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -340.6% | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.28% | n/a | n/a |